The Taste-Mood Diagnostic Study
This study is recruiting. It focuses on depression and currently lists participation information in the United Kingdom.
Key information made simple
This study is looking at whether questionnaires and follow-up can help people with Depression. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to questionnaires and follow-up, but direct benefit is not guaranteed.
Your next step
The official record suggests in-person participation through a lab, with sites including Jhoots Pharmacy in Bristol, Honiton Surgery, and Humber Teaching NHS Foundation Trust in Hull. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually matching the main diagnosis, while common reasons not to take part include safety concerns that need urgent care first and major medical issues that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Recruitment status
- Recruiting
- Estimated enrollment
- Not clearly listed
- Sponsor
- Ranvier Health Ltd
- Sponsor type
- Other organization
- Study type
- Diagnostic Test
- Intervention type
- Biological / biomarker / imaging
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- Over 18 Years
- Official registry ID
- NCT03645447
- Official source
- Official registry link
Want help reviewing this study?
Key study information
- Official title
- The Taste-Mood Diagnostic Study
- Condition
- Depression
- Study status
- Recruiting
- Sponsor / lead affiliation
- Ranvier Health Ltd
- Location / country
- United Kingdom
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT03645447
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in United Kingdom.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve biological samples, imaging, or biomarkers?
This appears to be a biological / biomarker / imaging study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.
Who might this study be for?
This study may concern people with depression; age range: Over 18 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to provide biological samples, complete lab tests, or take part in imaging or measurement procedures. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What should I check about samples, imaging, data, and possible discomfort?
If the study involves samples, imaging, or biomarkers, ask what is collected, how it is stored, who can access results, whether there may be discomfort, and whether results are shared with you. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Ranvier Health Ltd, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me
